NNC-92041706

N/A

Report date: 2025/04/16 11:22:33
NME

Base Information

Drug NameNNC-92041706
Drug Alias NameNNC9204-1706NNC-92041706NN-9423NNC-92041706-ANN-1706
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon receptor
Therapy Area/IndicationsObesityNutritional and Metabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsObesityNutritional and Metabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A